“I would like to continue to work closely with translational researchers to build rationally-designed protocols that exploit the diverse biology underlying lymphoma. I will also strive to carefully consider the impact these treatments will have on patients’ lives and plan to include patient-reported outcomes in my research endeavors,” says Dr. Erin Mulvey.
